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Case 25-2014: A Man with Ulcerative Colitis and Bloody 
Diarrhea
To the Editor: The Case Record contributed by 
Hohmann et al. (Aug. 14 issue),1 regarding a man 
with ulcerative colitis in whom bloody diarrhea 
developed soon after fecal microbiota transplan-
tation (FMT), highlights the difficulty in distin-
guishing cytomegalovirus (CMV) as a direct 
cause of disease from its being an “innocent by-
stander” in patients with CMV infection and ac-
tive ulcerative colitis. However, the authors also 
reported an apparent case of diarrheal disease 
caused by Blastocystis hominis transmitted by 
means of FMT without describing the complex 
debate as to whether this organism is a true en-
teropathogen. 
In developed countries, blastocystis is detect-
able in more than 50% of healthy persons with 
the use of polymerase-chain-reaction–based as-
says.2 No difference in the prevalence of blasto-
cystis exists between hosts with gastrointestinal 
symptoms and those without such symptoms,3 
and symptoms that are attributed to blastocystis 
infection may not improve even after the elimi-
nation of the organism.4 The organism has been 
shown to be capable of both long-term coloniza-
tion2 and spontaneous disappearance without 
intervention.4,5 Physicians offering FMT should 
carefully monitor FMT recipients for infectious 
complications but must be aware that presence 
is not the same as causation.
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The Discussant Replies: We understand the 
controversy surrounding B. hominis (an anaerobic 
protozoan), and the case referenced in the dis-
cussion, reported by a Canadian physician, high-
lights it nicely. The patient had recurrent Clostrid-
ium difficile infection, and the spousal donor, who 
had no gastrointestinal symptoms, had stool that 
tested positive for B. hominis (no other donor was 
readily available). The FMT cured the C. difficile 
infection, but intermittent loose stools lasting 
months subsequently developed, with positive 
tests for blastocystis. A course of nitazoxanide 
cured the symptoms. 
At a recent American Gastroenterological As-
sociation conference on FMT, physicians noted 
that blastocystis was a common finding in do-
nor stool specimens (e.g., in 6 of 38 specimens 
that were screened in an Australian study).1 The 
consensus of practitioners was that it would not 
be advisable to use such specimens for FMT. At-
tendees did not mention other cases of trans-
mission of infectious agents by FMT. Represen-
tatives of the Food and Drug Administration 
highlighted the possibility of transmission of 
currently unknown infectious agents and the 
need for judicious use and careful follow-up of 
recipients of FMT.
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 Catheterization of the Urethra in Girls
To the Editor: As Manzano et al. noted in their 
Video in Clinical Medicine (July 10 issue),1 it is 
sometimes difficult for the examiner to identify 
the urethral meatus when attempting to perform 
catheterization of the urinary bladder in girls. In 
such instances, it may be helpful to draw the la-
bial tissue upward by moving the nondominant 
hand anteriorly after spreading the labia majora 
with two fingers.2
If the meatus remains hard to visualize, we 
suggest enlisting an assistant for the following 
maneuver, which we term “labial lift.” Both the 
examiner and the assistant should gently grasp 
one of the labia majora — the examiner on the 
side of her nondominant hand and the assistant 
opposite. Together, they lift the labia anteriorly, 
laterally, and caudad (Fig. 1). As shown in the 
figure, using the corner of a small piece of ster-
ile gauze helps to maintain a comfortable hold 
on the labia, which may become slippery after 
sterile preparation. We have found that this 
technique seldom fails to allow the necessary 
visualization of the meatus.
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The authors reply: This is a very nice alterna-
tive to the use of downward traction to the ceph-
Figure 1. Labial Lift to Expose the Urethral Meatus 
in Girls.
The examiner gently grasps the labium majus on the 
side of her nondominant hand, while the assistant does 
so on the opposite side. Together, the labia are lifted 
anteriorly, laterally, and caudad to allow visualization 
of the urethral meatus.
Figure 1. Downward Traction of the Vaginal Mucosa.
The examiner localizes the meatus by gently pulling 
the cephalad fold of the vaginal introitus downward.
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